The digital rectal examination (DRE) remains important-outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy

Canadian Journal of Urology

Volumn 19, Issue 6, 2012, Pages 6542-6547

  Palmerola, Ricardo ^a   Smith, Paul ^a   Elliot, Vanessa ^a   Reese, Carl T ^a   Mahon, Frank B ^a   Harpster, Lewis E ^a   Icitovic, Nikolina ^a   Raman, Jay D ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Digital rectal examination; Prostate cancer; Prostate needle biopsy; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; BLOOD; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; DIGITAL RECTAL EXAMINATION; EARLY DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CORE NEEDLE BIOPSY; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; UNITED STATES; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY, LARGE-CORE NEEDLE; COHORT STUDIES; DIGITAL RECTAL EXAMINATION; EARLY DETECTION OF CANCER; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 84878457157     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2012. CA Cancer J Clin 2012;62(1):10-29.
2. Colli JL, Amling CL. Exploring causes for declining prostate cancer mortality rates in the United States. Urol Oncol 2008;26(6):627-633.
3. Greene KL, Albertsen PC, Babaian RJ et al. Prostate specific antigen best practice statement: 2009 update. J Urol 2009;182(5):2232-2241.
4. Nam RK, Saskin R, Lee Y et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010;183(3):963-968.
5. Matlaga B, Eskew L, McCullough D. Prostate biopsy: indications and technique. J Urol 2003;169(1):12-19.
6. Epstein J, Potter S. The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol 2001;166(2):402-410.
7. Thompson IM, Pauler DK, Goodman PJ et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 2004;350(22):2239-2246.
8. Catalona WJ, Partin AW, Slawin KM et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic diseases. JAMA 1998; 279(19):1542-1547.
9. Andriole Gl, Levin DL, Crawford ED et al. Prostate cancer screening in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst 2005;97(6):433-438.
10. Crawford ED, DeAntoni EP, Etzioni R et al. Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. The Prostate Cancer Education Council. Urology 1996;47(6):863-869.
11. Carvalhal G, Smith DS, Mager DE et al. Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less. J Urol 1999;161(3):835-839.
12. Richie JP, Catalona WJ, Ahmann FR et al. Effect on patient age on early detection of prostate cancer with serum prostate specific antigen and digital rectal examination. Urology 1993;42(4):365-374.
13. Siu W, Dunn RL, Shah RB et al. Use of extended pattern technique for initial prostate biopsy. J Urol 2005;174(2):505-509.
14. Schroder FH, Hugosson J, Roobol MJ et al. Screening and prostate cancer mortality in a randomized European study. N Engl J Med 2009;360(13):1320-1328.
15. Schroder FH, van der Maas P, Beemsterboer P et al. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of screening for prostate cancer. J Natl Cancer Inst 1998;90(23): 1817-1823.
16. Catalona WJ, Richie JP, Ahmann FR et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151(5):1283-1290.
17. Bozeman CB, Carver BS, Caldito G et al. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate specific antigen less than 4.0 ng/mL. Urology 2005; 66(4): 803-807.
18. Ford ME, Havstad SL, Demers R et al. Effects of false-positive prostate cancer screening results on subsequent prostate cancer screening behavior. Cancer Epidemiol Biomarkers Prev 2005;14(1): 190-194.
19. Reed A, Ankerst DP, Pollock BH, Thompson IM, Parekh DJ. Current age and race adjusted Prostate specific antigen values delay diagnosis of high grade prostate cancer. J Urol 2007;178(5): 1929-1932.
20. Wu, I, Nielsen ME, Han M, Partin AW, Makarov DV. Does laterality of positive needle biopsy in clinical T2a prostate cancer patients affect biochemical recurrence free survival? Urology 2008;72(6): 1219-1223.